How Has the Endometriosis Market Evolved Historically and What is its Current Size?
The endometriosis market has seen considerable growth due to a variety of factors.
• The market size of endometriosis has seen significant expansion in the recent past. The market is predicted to increase from $1.4 billion in 2024 to $1.55 billion in 2025, fuelled by a compound annual growth rate (CAGR) of 10.2%.
The considerable growth during the historical period is due to factors such as later diagnosis and heightened awareness, advancements in laparoscopic surgery, hormonal treatments, along with patient advocacy and support groups.
What Is The Projected Growth Of The Endometriosis Template Market?
The endometriosis market is expected to maintain its strong growth trajectory in upcoming years.
• Over the next several years, considerable expansion is anticipated for the endometriosis market. The estimated increase would bring the value up to $2.21 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%.
The predicted progress during this forecast period is linked to the introduction of minimally invasive procedures, advancements in pharmaceuticals, and developments in genetic and epigenetic research, along with ongoing global improvements in women's healthcare. The forthcoming period also expects to witness significant trends such as patient-focused care, precision medicine, virtual care and telemedicine, as well as fertility preservation.
What Are The Key Drivers Fueling Growth In The Endometriosis Market?
The rise in ovarian cancer cases is anticipated to stimulate the expansion of the endometriosis market. Originating in the ovaries - the female reproductive organs that produce eggs as well as estrogen and progesterone hormones - ovarian cancer has been linked to a greater likelihood of being diagnosed with epithelial ovarian cancer, specifically the endometrioid and clear cell cancer subtypes. These subtypes are marked by high levels of estrogen, escalating the potential threat of ovarian cancer. By January 2023, the American Cancer Society forecasts that nearly 19,710 fresh incidences of ovarian cancer will be discovered among U.S. women. Ovarian Cancer Research Alliance also reported in 2022 that ovarian cancer was responsible for 12,810 deaths, a figure that rose to 13,270 by 2023. Such a rise in ovarian cancer cases is contributing to the endometriosis market's growth. The headline "Endometriosis Market Driver: Government Funding Boosting Endometriosis Market Growth" refers to the expected endometriosis market growth due to an increase in government funding. Such funding is financial aid provided by the government to non-government bodies, typically through grants or contracts awarded for clinical research. For example, in March 2022 the U.S. federal government invested $92 million into the National Institute of Child Health and Human Development (NICHD) and earmarked $370 million for the Department of Defense's Peer-Reviewed Medical Research Programme (PRMRP) in support of endometriosis research. Thus, government funding is a critical driver of the endometriosis market's growth.
What Are The Principal Market Segments In The Global Endometriosis Industry?
The endometriosis market covered in this report is segmented –
1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types
2) By Treatment Type: Hormonal Therapy, Pain Management
3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs
4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Superficial Peritoneal Lesion: Endometriotic Nodules, Peritoneal Endometriosis
2) By Endometrioma: Chocolate Cysts
3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis, Ureteral Endometriosis, Vaginal Endometriosis
4) By Other Types: Abdominal Endometriosis, Thoracic Endometriosis
Pre-Book The Endometriosis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Endometriosis Market?
Leading entities in the endometriosis market are concentrating on the creation and regulatory approval of innovative drugs like Myfembree to expand patient treatment alternatives. The advent of these advanced medicines fulfills a long-existing market gap for effective endometriosis treatment. For example, in August 2022, both Switzerland's Myovant Sciences GmbH and America's Pfizer Inc. received the green light from the U.S. Food and Drug Administration (FDA) to distribute Myfembree for managing moderate to intense endometriosis-related pain in premenopausal women. As a daily pill boasting three key ingredients – relugolix, estradiol, and norethindrone acetate – Myfembree offers confirmed respite for premenopausal women, addressing two indications with a single pill. Subsequently, this serves as an alternative remedy for women preferring to avoid hormone therapy or where such therapy isn't viable.
Who Are the Key Players In The Endometriosis Market?
Major companies operating in the endometriosis market are:
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Merck And Co. Inc.
• Abbvie Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• GlaxoSmithKline PLC
• AstraZeneca PLC
• Abbott Laboratories
• Eli Lilly and Company
• Mylan N.V.
• Astellas Pharma Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Limited
• Ipsen Pharma Biotech S.A.S.
• Cadila Pharmaceuticals Ltd.
• Gedeon Richter PLC
• Torrent Pharmaceuticals Ltd.
• Neurocrine Biosciences Inc.
• Ferring Pharmaceuticals
• Prestige Consumer Healthcare Inc.
• Almirall S.A
• Evotec BioSystems GmbH
• Serum Institute of India Pvt. Ltd.
• Kissei Pharmaceutical Co. Ltd.
• Sanofi India Ltd.
• DebioPharm Group
• Repros Therapeutics Inc.
• Meditrina Pharmaceuticals Private Limited
• Zenomed Healthcare Private Limited.
What Are The Regional Insights Into The Endometriosis Market?
North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
